End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
82.7 EUR | -5.27% |
|
-5.27% | -13.39% |
18/06 | US FDA Places Partial Clinical Hold on BioNTech's Cancer Drug Trial | MT |
17/06 | Sector Update: Health Care Stocks Ease in Afternoon Trading | MT |
Sales 2024 * | 274.51Cr 293.48Cr 25TCr | Sales 2025 * | 273.95Cr 292.88Cr 24TCr | Capitalization | 1.91TCr 2.04TCr 1,70800Cr |
---|---|---|---|---|---|
Net income 2024 * | -42Cr -45Cr -3.74TCr | Net income 2025 * | -55Cr -59Cr -4.9TCr | EV / Sales 2024 * | 2.35 x |
Net cash position 2024 * | 1.27TCr 1.35TCr 1,13200Cr | Net cash position 2025 * | 1.2TCr 1.29TCr 1,07400Cr | EV / Sales 2025 * | 2.59 x |
P/E ratio 2024 * |
-43.8
x | P/E ratio 2025 * |
-34.7
x | Employees | 6,133 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.48% |
Latest transcript on BioNTech SE
1 day | -5.27% | ||
1 week | -5.27% | ||
Current month | -10.16% | ||
1 month | -10.35% | ||
3 months | -2.34% | ||
6 months | -13.64% | ||
Current year | -13.39% |
![Extreme 78.75](/images/extremecours_fleche.png)
![Extreme 78.75](/images/extremecours_fleche.png)
![Extreme 78.75](/images/extremecours_fleche.png)
![Extreme 78.75](/images/extremecours_fleche.png)
![Extreme 78.75](/images/extremecours_fleche.png)
![Extreme 65.89](/images/extremecours_fleche.png)
![Extreme 65.89](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Ugur Sahin
CEO | Chief Executive Officer | 58 | 02/08/02 |
Özlem Türeci
FOU | Founder | 57 | 02/08/02 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rudolf Staudigl
BRD | Director/Board Member | 70 | 01/22/01 |
Director/Board Member | 67 | 02/08/02 | |
Helmut Jeggle
CHM | Chairman | 53 | 02/08/02 |
Date | Price | Change | Volume |
---|---|---|---|
21/24/21 | 78.75 | -2.11% | 0 |
20/24/20 | 80.45 | +0.31% | 0 |
19/24/19 | 80.2 | -1.35% | 4 |
18/24/18 | 81.3 | -1.69% | 0 |
17/24/17 | 82.7 | -5.27% | 10 |
End-of-day quote Wiener Boerse, June 17, 2024
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.19% | 12TCr | |
+19.91% | 11TCr | |
+8.24% | 2.36TCr | |
-16.19% | 1.65TCr | |
-13.45% | 1.64TCr | |
-44.35% | 1.56TCr | |
+66.67% | 1.52TCr | |
+2.13% | 1.35TCr | |
+119.39% | 1.1TCr |
- Stock Market
- Equities
- BNTX Stock
- BNTX Stock